---
title: acuteÂ myelogenousÂ leukemiaÂ (AML)
alias: AML
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ğŸŒ± ä¾†è‡ªï¼š[[leukemia]]

# acuteÂ myelogenousÂ leukemiaÂ (AML)

AML æ˜¯ï¼šè€å¹´æ‚£è€…ä¸­æœ€å¸¸è¦‹çš„ â†’ æ€¥æ€§ç™½è¡€ç—…ï¼Œè¨ºæ–·æ™‚çš„ â†’ ä¸­ä½å¹´é½¡ ç‚ºï¼š67 æ­²

- é•·æœŸå­˜æ´»çš„ â†’ æƒ…æ³å¾ˆå°‘è¦‹ï¼›ç¾åœ‹è¨»å†Šæ•¸æ“šå ±å‘Šèªªï¼Œåªæœ‰ 27% çš„ â†’ æ‚£è€…èƒ½å­˜æ´» 5 å¹´ã€‚

- [[classification of acute myelogenous leukemia (AML)|acute myelogenous leukemia çš„ â†’ åˆ†é¡æœ‰å“ªäº›ï¼Ÿ]]
- [[ENL 2017 Genetic Risk Classification|ENL æ˜¯ï¼šæ€éº¼åˆ†çš„ â†’ å•Šâ€¦]]
- [[upfront treatment of acute myelogenous leukemia (AML)|acute myelogenous leukemia æœ‰å“ªäº›æ–°çš„ â†’ æ²»ç™‚ï¼Ÿ]]
- [[consolidation therapy of acute myelogenous leukemia (AML)]]
- [[prognosis of acute myelogenous leukemia (AML)]]
- [[acute promyelocytic leukemia (APL)]]
- [[topics-of-acute myelogenous leukemia.md|Topics-of-acute myelogenous leukemia]]
